囊括腹膜硬化症的结果:对营养参数变化的意义的回顾性研究
Chih-Ying Chien1, Ming-Tsun Tsai1,2, Jinn-Yang Chen1,2
1Division of Nephrology, Department of Internal Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, 11217, Taiwan.
BMC nephrology
|September 1, 2025
概括
在封装性腹膜硬化 (EPS) 患者中,监测一个月的白蛋白下降至关重要. 这一发现预测死亡率,并有助于治疗腹腔透析的严重并发症.
科学领域:
- 肝脏病学
- 胃肠病学
- 临床医学
背景情况:
- 囊括性腹膜硬化 (EPS) 是腹膜透析 (PD) 的严重并发症,死亡率高.
- 虽然已知EPS风险因素,但影响患者结果的预后因素仍未得到充分研究.
- 这项研究调查了EPS患者的临床过程和生存预测因素.
研究的目的:
- 确定影响封闭性腹膜硬化症 (EPS) 诊断患者的临床过程和生存的预后因素.
主要方法:
- 对1406名经过18年内腹腔透析的患者进行了回顾性分析,其中35人被诊断患有EPS.
- 收集的数据包括人口统计,并发症,PD参数,症状,CT得分,实验室和治疗方法.
- 使用单变量/多变量考克斯回归和卡普兰-梅尔方法进行生存分析.
主要成果:
- 患者经常出现肠道阻塞 (88. 6%) 和超过失败 (42. 9%).
- 五年生存率为26.3%, 营养不良和感染导致大多数死亡.
- 一个月的白蛋白水平下降预测了整体 (HR 2.01) 和与EPS相关的 (HR 2.79) 死亡率.
结论:
- 在EPS诊断后,白蛋白水平显著下降是死亡率的关键预测因素.
- 监测白蛋白水平为改善EPS的临床管理和患者护理提供了宝贵的见解.
- 这一发现突显了营养状况评估对EPS预后的重要性.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
105
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
105
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
282
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
282
Peritoneal Dialysis III: Nursing Management
140
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
140


